27 Aug 2026 - The clinical stage radiopharmaceutical company unveiled its preliminary final report, highlighting a strategic focus on research and development and robust balance sheet growth for the year ended 30 June 2026.
27 Aug 2026 - Technology and debt collection provider sees revenue and earnings climb, driven by organic expansion and successful UK acquisitions, amidst ACCC investigation update.
0 min
About Latest Company News - Finance News Network
From the publisher's feed
The latest Company News from Finance News Network.